SCHEMBL13340252

SCHEMBL13340252

c1ccc(-c2cc(-c3ccccc3)c3c4ccccc4c4ccccc4c3c2-c2ccc(N3CCCc4ccccc43)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.39
TP53 P04637 2/20 0.36
LMNA P02545 4/20 0.35
RECQL P46063 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
EED O75530 1/20 0.35
ROCK1 Q13464 1/20 0.34
KDM4E B2RXH2 4/20 0.34
HSD17B10 Q99714 2/20 0.34
CYP1A2 P05177 1/20 0.34
AKT1 P31749 1/20 0.34
PIK3CA P42336 1/20 0.34
AVPR2 P30518 1/20 0.34
OXTR P30559 1/20 0.34
AVPR1A P37288 1/20 0.34
NUDT1 P36639 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
MAPT P10636 5/20 0.33
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13340298 1.00 OPRM1 (0.39) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13340325 1.00 OPRM1 (0.39) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13339228 0.93 OPRM1 (0.38) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13340331 0.93 OPRM1 (0.35) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13340269 0.93 OPRM1 (0.35) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13340228 0.92 OPRM1 (0.39) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13340213 0.91 OPRM1 (0.39) OPRM1TP53LMNARECQLL3MBTL1
SCHEMBL13340270 0.89 OPRM1 (0.37) OPRM1TP53LMNAL3MBTL1EED
SCHEMBL13340334 0.89 OPRM1 (0.33) OPRM1TP53LMNAEEDKDM4E
SCHEMBL13340302 0.83 HSD17B3 (0.33) L3MBTL1KDM4EMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100108997-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OR10J3, OCIAD1, OCIAD2 OPRM1 9/4885TP53 4247/4885LMNA 4085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.